Cargando…
Linagliptin: from bench to bedside
PURPOSE: The nature of biomedical research affords a broad range of investigational topics at the preclinical stage, not all of which may be explored in subsequent clinical studies. To provide a comprehensive perspective on the physiologic effects of the dipeptidyl peptidase-4 inhibitor linagliptin,...
Autor principal: | Doupis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018312/ https://www.ncbi.nlm.nih.gov/pubmed/24851042 http://dx.doi.org/10.2147/DDDT.S59523 |
Ejemplares similares
-
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008) -
Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023) -
Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021) -
MEK and the inhibitors: from bench to bedside
por: Akinleye, Akintunde, et al.
Publicado: (2013)